DOCSLIB.ORG

Mouse Rabepk Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Rabepk Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Rabepk Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Rabepk conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Rabepk gene (NCBI Reference Sequence: NM_145522 ; Ensembl: ENSMUSG00000070953 ) is located on Mouse chromosome 2. 8 exons are identified, with the ATG start codon in exon 1 and the TAA stop codon in exon 8 (Transcript: ENSMUST00000145903). Exon 3 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Rabepk gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-347M2 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 3 starts from about 6.84% of the coding region. The knockout of Exon 3 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 2045 bp, and the size of intron 3 for 3'-loxP site insertion: 4516 bp. The size of effective cKO region: ~658 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 2 3 8 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Rabepk Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7158bp) | A(27.06% 1937) | C(22.32% 1598) | T(27.83% 1992) | G(22.79% 1631) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr2 - 34795580 34798579 3000 browser details YourSeq 143 210 2641 3000 88.7% chr17 + 80163711 80212998 49288 browser details YourSeq 127 208 565 3000 92.2% chr1 + 90926800 91007556 80757 browser details YourSeq 124 402 579 3000 84.3% chr19 - 34892759 34892926 168 browser details YourSeq 124 413 578 3000 87.9% chr10 - 64499971 64500141 171 browser details YourSeq 111 149 548 3000 88.9% chr1 - 165619062 165791893 172832 browser details YourSeq 105 207 578 3000 88.9% chr15 + 73444296 73681967 237672 browser details YourSeq 103 425 570 3000 88.8% chr15 - 55188469 55188614 146 browser details YourSeq 98 413 548 3000 89.7% chr9 + 14310992 14342836 31845 browser details YourSeq 95 431 576 3000 83.6% chr16 + 89260275 89260417 143 browser details YourSeq 94 418 577 3000 94.4% chr14 - 16296454 16296615 162 browser details YourSeq 93 389 548 3000 90.5% chr1 + 95151008 95151169 162 browser details YourSeq 88 461 570 3000 88.1% chr1 - 52789135 52789243 109 browser details YourSeq 88 418 579 3000 89.4% chr11 + 4521749 4521912 164 browser details YourSeq 88 466 579 3000 88.9% chr1 + 155522161 155522273 113 browser details YourSeq 85 426 548 3000 87.5% chr6 - 47869438 47869560 123 browser details YourSeq 85 461 580 3000 85.6% chr10 - 31399645 31400189 545 browser details YourSeq 82 465 571 3000 88.7% chr1 + 59908946 59909053 108 browser details YourSeq 82 461 588 3000 85.6% chr1 + 34428991 34429115 125 browser details YourSeq 81 427 581 3000 85.9% chr11 - 63295265 63295417 153 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr2 - 34791922 34794921 3000 browser details YourSeq 370 1 716 3000 87.4% chr8 - 68110118 68347705 237588 browser details YourSeq 247 2291 2602 3000 92.5% chr15 + 76665495 76665870 376 browser details YourSeq 244 2067 2604 3000 94.6% chr11 + 23502136 23502808 673 browser details YourSeq 234 2350 2745 3000 93.7% chr11 - 72555273 72555698 426 browser details YourSeq 233 21 594 3000 83.8% chr5 + 91704321 91704923 603 browser details YourSeq 230 19 754 3000 81.6% chr1 - 10177753 10178267 515 browser details YourSeq 229 1 318 3000 87.3% chr3 - 66329908 66330228 321 browser details YourSeq 213 1 311 3000 85.0% chr13 - 106673684 106673975 292 browser details YourSeq 195 1 305 3000 85.1% chr1 - 97565280 97565587 308 browser details YourSeq 194 1 318 3000 84.7% chr5 + 112176663 112177022 360 browser details YourSeq 193 1 318 3000 85.2% chr14 - 33584925 33585222 298 browser details YourSeq 192 1 705 3000 83.3% chr16 - 18742198 18742841 644 browser details YourSeq 191 1 318 3000 82.7% chr5 - 113594046 113677020 82975 browser details YourSeq 190 1971 2394 3000 95.7% chr9 + 78619762 78620212 451 browser details YourSeq 189 1 305 3000 83.0% chr8 + 22841032 22841337 306 browser details YourSeq 188 1 310 3000 82.2% chr14 - 60134102 60134393 292 browser details YourSeq 188 2413 2605 3000 99.0% chr3 + 19202731 19202936 206 browser details YourSeq 187 11 303 3000 86.6% chr9 - 15364253 15364525 273 browser details YourSeq 187 2414 2603 3000 99.5% chr16 - 17866768 17866958 191 Note: The 3000 bp section downstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Rabepk Rab9 effector protein with kelch motifs [ Mus musculus (house mouse) ] Gene ID: 227746, updated on 9-Oct-2019 Gene summary Official Symbol Rabepk provided by MGI Official Full Name Rab9 effector protein with kelch motifs provided by MGI Primary source MGI:MGI:2139530 See related Ensembl:ENSMUSG00000070953 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as C87311; Rab9p40; AV073337; 8430412M01Rik; 9530020D24Rik Expression Broad expression in testis adult (RPKM 48.4), genital fat pad adult (RPKM 5.2) and 18 other tissues See more Orthologs human all Genomic context Location: 2; 2 B See Rabepk in Genome Data Viewer Exon count: 9 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 2 NC_000068.7 (34774609..34800196, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 2 NC_000068.6 (34634186..34655311, complement) Chromosome 2 - NC_000068.7 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 7 transcripts Gene: Rabepk ENSMUSG00000070953 Description Rab9 effector protein with kelch motifs [Source:MGI Symbol;Acc:MGI:2139530] Gene Synonyms 8430412M01Rik, 9530020D24Rik Location Chromosome 2: 34,777,556-34,799,912 reverse strand. GRCm38:CM000995.2 About this gene This gene has 7 transcripts (splice variants), 208 orthologues, 10 paralogues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Rabepk- ENSMUST00000145903.7 2968 380aa ENSMUSP00000122360.1 Protein coding CCDS15951 Q8VCH5 TSL:1 207 GENCODE basic Rabepk- ENSMUST00000118108.1 1431 372aa ENSMUSP00000113099.1 Protein coding - B0R0S4 TSL:5 203 GENCODE basic APPRIS P1 Rabepk- ENSMUST00000113086.8 1106 321aa ENSMUSP00000108709.2 Protein coding - A2AUF7 TSL:5 202 GENCODE basic Rabepk- ENSMUST00000140663.7 1223 52aa ENSMUSP00000122119.1 Nonsense mediated - D6RGR6 TSL:2 204 decay Rabepk- ENSMUST00000047963.6 763 64aa ENSMUSP00000037746.6 Nonsense mediated - G8JL41 CDS 5' 201 decay incomplete TSL:3 Rabepk- ENSMUST00000141099.1 542 76aa ENSMUSP00000120887.1 Nonsense mediated - D6RHN6 TSL:3 205 decay Rabepk- ENSMUST00000144113.1 600 No - Retained intron - - TSL:2 206 protein Page 6 of 8 https://www.alphaknockout.com 42.36 kb Forward strand 34.77Mb 34.78Mb 34.79Mb 34.80Mb Genes Hspa5-201 >protein coding (Comprehensive set... Hspa5-202 >protein coding Hspa5-204 >nonsense mediated decay Hspa5-205 >retained intron Hspa5-206 >retained intron Hspa5-203 >retained intron Contigs AL929106.5 > Genes (Comprehensive set... < Rabepk-207protein coding < Fbxw2-201protein coding < Rabepk-202protein coding < Fbxw2-205protein coding < Rabepk-203protein coding < Fbxw2-202protein coding < Rabepk-201nonsense mediated decay < Fbxw2-206protein coding < Rabepk-205nonsense mediated decay < Fbxw2-204protein coding < Rabepk-204nonsense mediated decay < Fbxw2-203protein coding < Rabepk-206retained intron < Fbxw2-213lncRNA < Fbxw2-210lncRNA Regulatory Build 34.77Mb 34.78Mb 34.79Mb 34.80Mb Reverse strand 42.36 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding RNA gene processed transcript Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000145903 < Rabepk-207protein coding Reverse strand 22.36 kb ENSMUSP00000122... Low complexity (Seg) Superfamily Kelch-type beta propeller Pfam Kelch repeat type 2 PF13415 Kelch repeat type 1 PANTHER PTHR46647 Gene3D Kelch-type beta propeller All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 40 80 120 160 200 240 280 320 380 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Genetic and Genomic Analysis of Hyperlipidemia, Obesity and Diabetes Using (C57BL/6J × TALLYHO/Jngj) F2 Mice
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Nutrition Publications and Other Works Nutrition 12-19-2010 Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P. Stewart Marshall University Hyoung Y. Kim University of Tennessee - Knoxville, [email protected] Arnold M. Saxton University of Tennessee - Knoxville, [email protected] Jung H. Kim Marshall University Follow this and additional works at: https://trace.tennessee.edu/utk_nutrpubs Part of the Animal Sciences Commons, and the Nutrition Commons Recommended Citation BMC Genomics 2010, 11:713 doi:10.1186/1471-2164-11-713 This Article is brought to you for free and open access by the Nutrition at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Nutrition Publications and Other Works by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Stewart et al. BMC Genomics 2010, 11:713 http://www.biomedcentral.com/1471-2164/11/713 RESEARCH ARTICLE Open Access Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6J × TALLYHO/JngJ) F2 mice Taryn P Stewart1, Hyoung Yon Kim2, Arnold M Saxton3, Jung Han Kim1* Abstract Background: Type 2 diabetes (T2D) is the most common form of diabetes in humans and is closely associated with dyslipidemia and obesity that magnifies the mortality and morbidity related to T2D. The genetic contribution to human T2D and related metabolic disorders is evident, and mostly follows polygenic inheritance. The TALLYHO/ JngJ (TH) mice are a polygenic model for T2D characterized by obesity, hyperinsulinemia, impaired glucose uptake and tolerance, hyperlipidemia, and hyperglycemia.
    [Show full text]
  • 1 Title 1 Loss of PABPC1 Is Compensated by Elevated PABPC4
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.07.430165; this version posted February 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 1 Title 2 Loss of PABPC1 is compensated by elevated PABPC4 and correlates with transcriptome 3 changes 4 5 Jingwei Xie1, 2, Xiaoyu Wei1, Yu Chen1 6 7 1 Department of Biochemistry and Groupe de recherche axé sur la structure des 8 protéines, McGill University, Montreal, Quebec H3G 0B1, Canada 9 10 2 To whom correspondence should be addressed: Dept. of Biochemistry, McGill 11 University, Montreal, QC H3G 0B1, Canada. E-mail: [email protected]. 12 13 14 15 Abstract 16 Cytoplasmic poly(A) binding protein (PABP) is an essential translation factor that binds to 17 the 3' tail of mRNAs to promote translation and regulate mRNA stability. PABPC1 is the 18 most abundant of several PABP isoforms that exist in mammals. Here, we used the 19 CRISPR/Cas genome editing system to shift the isoform composition in HEK293 cells. 20 Disruption of PABPC1 elevated PABPC4 levels. Transcriptome analysis revealed that the 21 shift in the dominant PABP isoform was correlated with changes in key transcriptional 22 regulators. This study provides insight into understanding the role of PABP isoforms in 23 development and differentiation. 24 Keywords 25 PABPC1, PABPC4, c-Myc 26 bioRxiv preprint doi: https://doi.org/10.1101/2021.02.07.430165; this version posted February 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • RAB9 Antibody (R32125)
    RAB9 Antibody (R32125) Catalog No. Formulation Size R32125 0.5mg/ml if reconstituted with 0.2ml sterile DI water 100 ug Bulk quote request Availability 1-3 business days Species Reactivity Human, Mouse, Rat Format Antigen affinity purified Clonality Polyclonal (rabbit origin) Isotype Rabbit IgG Purity Antigen affinity Buffer Lyophilized from 1X PBS with 2.5% BSA and 0.025% sodium azide UniProt P51151 Applications Western blot : 0.1-0.5ug/ml Limitations This RAB9 antibody is available for research use only. Western blot testing of 1) rat brain, 2) mouse brain, 3) human HeLa and 4) human MCF7 lysate with RAB9 antibody. Expected/observed molecular weight: ~23 kDa. Description Ras-related protein Rab-9A, also called RAB9, is a protein that in humans is encoded by the RAB9A gene. This gene is mapped to Xp22.2. RAB9 has been localized to components of the endocytic/exocytic pathway and has been implicated in recycling of membrane receptors. It has been found that downregulation of RAB9A gene expression in HeLa cells induced severe cell vacuolation. RAB9A GTPase is directly bound by TIP47 in its active, GTP-bound conformation. Moreover, RAB9A increases the affinity of TIP47 for its cargo. What’s more, this gene may involved in the transport of proteins between the endosomes and the trans Golgi network. RAB9A has been shown to interact with RABEPK and TIP47. Application Notes Optimal dilution of the RAB9 antibody should be determined by the researcher. Immunogen Amino acids KDATNVAAAFEEAVRRVLATEDRSDHLIQTDTVNLHRK of human RAB9A were used as the immunogen for the RAB9 antibody. Storage After reconstitution, the RAB9 antibody can be stored for up to one month at 4oC.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Mapping of Craniofacial Traits in Outbred Mice Identifies Major Developmental Genes Involved in Shape Determination
    Mapping of craniofacial traits in outbred mice identifies major developmental genes involved in shape determination Luisa F Pallares1, Peter Carbonetto2,3, Shyam Gopalakrishnan2,4, Clarissa C Parker2,5, Cheryl L Ackert-Bicknell6, Abraham A Palmer2,7, Diethard Tautz1 # 1Max Planck Institute for Evolutionary Biology, Plön, Germany 2University of Chicago, Chicago, Illinois, USA 3AncestryDNA, San Francisco, California, USA 4Museum of Natural History, Copenhagen University, Copenhagen, Denmark 5Middlebury College, Department of Psychology and Program in Neuroscience, Middlebury VT, USA 6Center for Musculoskeletal Research, University of Rochester, Rochester, NY USA 7University of California San Diego, La Jolla, CA, USA # corresponding author: [email protected] short title: craniofacial shape mapping Abstract The vertebrate cranium is a prime example of the high evolvability of complex traits. While evidence of genes and developmental pathways underlying craniofacial shape determination 1 is accumulating, we are still far from understanding how such variation at the genetic level is translated into craniofacial shape variation. Here we used 3D geometric morphometrics to map genes involved in shape determination in a population of outbred mice (Carworth Farms White, or CFW). We defined shape traits via principal component analysis of 3D skull and mandible measurements. We mapped genetic loci associated with shape traits at ~80,000 candidate single nucleotide polymorphisms in ~700 male mice. We found that craniofacial shape and size are highly heritable, polygenic traits. Despite the polygenic nature of the traits, we identified 17 loci that explain variation in skull shape, and 8 loci associated with variation in mandible shape. Together, the associated variants account for 11.4% of skull and 4.4% of mandible shape variation, however, the total additive genetic variance associated with phenotypic variation was estimated in ~45%.
    [Show full text]
  • Understanding and Improving the Identification of Somatic Variants
    Understanding and Improving the Identification of Somatic Variants Vinaya Vijayan Dissertation submitted to the faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy In Genetics, Bioinformatics and Computational Biology Chair: Liqing Zhang Christopher Franck Lenwood S. Heath Xiaowei Wu August 12th, 2016 Blacksburg, VA, USA Keywords: Somatic variants, Somatic variant callers, Somatic point mutations, Short tandem repeat variation, Lung squamous cell carcinoma Understanding and Improving the Identification of Somatic Variants Vinaya Vijayan ABSTRACT It is important to understand the entire spectrum of somatic variants to gain more insight into mutations that occur in different cancers for development of better diagnostic, prognostic and therapeutic tools. This thesis outlines our work in understanding somatic variant calling, improving the identification of somatic variants from whole genome and whole exome platforms and identification of biomarkers for lung cancer. Integrating somatic variants from whole genome and whole exome platforms poses a challenge as variants identified in the exonic regions of the whole genome platform may not be identified on the whole exome platform and vice-versa. Taking a simple union or intersection of the somatic variants from both platforms would lead to inclusion of many false positives (through union) and exclusion of many true variants (through intersection). We develop the first framework to improve the identification of somatic variants on whole genome and exome platforms using a machine learning approach by combining the results from two popular somatic variant callers. Testing on simulated and real data sets shows that our framework identifies variants more accurately than using only one somatic variant caller or using variants from only one platform.
    [Show full text]
  • Proteomicsdb: a Multi-Omics and Multi-Organism Resource for Life Science
    Published online 30 October 2019 Nucleic Acids Research, 2020, Vol. 48, Database issue D1153–D1163 doi: 10.1093/nar/gkz974 ProteomicsDB: a multi-omics and multi-organism resource for life science research Patroklos Samaras 1, Tobias Schmidt 1,MartinFrejno1, Siegfried Gessulat1,2, Maria Reinecke1,3,4, Anna Jarzab1, Jana Zecha1, Julia Mergner1, Piero Giansanti1, Hans-Christian Ehrlich2, Stephan Aiche2, Johannes Rank5,6, Harald Kienegger5,6, Helmut Krcmar5,6, Bernhard Kuster1,7,* and Mathias Wilhelm1,* 1Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Bavaria, Germany, 2Innovation Center Network, SAP SE, Potsdam, Germany, 3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany, 4German Cancer Research Center (DKFZ), Heidelberg, Germany, 5Chair for Information Systems, Technical University of Munich (TUM), Garching, Germany, 6SAP University Competence Center, Technical University of Munich (TUM), Garching, Germany and 7Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), Technical University of Munich (TUM), Freising, Bavaria, Germany Received September 14, 2019; Revised October 11, 2019; Editorial Decision October 11, 2019; Accepted October 15, 2019 ABSTRACT INTRODUCTION ProteomicsDB (https://www.ProteomicsDB.org) ProteomicsDB (https://www.ProteomicsDB.org) is an in- started as a protein-centric in-memory database for memory database initially developed for the exploration of the exploration of large collections of quantitative large quantities of quantitative human mass spectrometry- mass spectrometry-based proteomics data. The based proteomics data including the first draft of the hu- data types and contents grew over time to include man proteome (1). Among many features, it allows the real- time exploration and retrieval of protein abundance values RNA-Seq expression data, drug-target interactions across different tissues, cell lines, and body fluids via inter- and cell line viability data.
    [Show full text]
  • Predict AID Targeting in Non-Ig Genes Multiple Transcription Factor
    Downloaded from http://www.jimmunol.org/ by guest on September 26, 2021 is online at: average * The Journal of Immunology published online 20 March 2013 from submission to initial decision 4 weeks from acceptance to publication Multiple Transcription Factor Binding Sites Predict AID Targeting in Non-Ig Genes Jamie L. Duke, Man Liu, Gur Yaari, Ashraf M. Khalil, Mary M. Tomayko, Mark J. Shlomchik, David G. Schatz and Steven H. Kleinstein J Immunol http://www.jimmunol.org/content/early/2013/03/20/jimmun ol.1202547 Submit online. Every submission reviewed by practicing scientists ? is published twice each month by http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://www.jimmunol.org/content/suppl/2013/03/20/jimmunol.120254 7.DC1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 26, 2021. Published March 20, 2013, doi:10.4049/jimmunol.1202547 The Journal of Immunology Multiple Transcription Factor Binding Sites Predict AID Targeting in Non-Ig Genes Jamie L. Duke,* Man Liu,†,1 Gur Yaari,‡ Ashraf M. Khalil,x Mary M. Tomayko,{ Mark J. Shlomchik,†,x David G.
    [Show full text]
  • Supplementary Table 3. Genes Specifically Regulated by Zol (Non-Significant for Fluva)
    Supplementary Table 3. Genes specifically regulated by Zol (non-significant for Fluva). log2 Genes Probe Genes Symbol Genes Title Zol100 vs Zol vs Set ID Control (24h) Control (48h) 8065412 CST1 cystatin SN 2,168 1,772 7928308 DDIT4 DNA-damage-inducible transcript 4 2,066 0,349 8154100 VLDLR very low density lipoprotein 1,99 0,413 receptor 8149749 TNFRSF10D tumor necrosis factor receptor 1,973 0,659 superfamily, member 10d, decoy with truncated death domain 8006531 SLFN5 schlafen family member 5 1,692 0,183 8147145 ATP6V0D2 ATPase, H+ transporting, lysosomal 1,689 0,71 38kDa, V0 subunit d2 8013660 ALDOC aldolase C, fructose-bisphosphate 1,649 0,871 8140967 SAMD9 sterile alpha motif domain 1,611 0,66 containing 9 8113709 LOX lysyl oxidase 1,566 0,524 7934278 P4HA1 prolyl 4-hydroxylase, alpha 1,527 0,428 polypeptide I 8027002 GDF15 growth differentiation factor 15 1,415 0,201 7961175 KLRC3 killer cell lectin-like receptor 1,403 1,038 subfamily C, member 3 8081288 TMEM45A transmembrane protein 45A 1,342 0,401 8012126 CLDN7 claudin 7 1,339 0,415 7993588 TMC7 transmembrane channel-like 7 1,318 0,3 8073088 APOBEC3G apolipoprotein B mRNA editing 1,302 0,174 enzyme, catalytic polypeptide-like 3G 8046408 PDK1 pyruvate dehydrogenase kinase, 1,287 0,382 isozyme 1 8161174 GNE glucosamine (UDP-N-acetyl)-2- 1,283 0,562 epimerase/N-acetylmannosamine kinase 7937079 BNIP3 BCL2/adenovirus E1B 19kDa 1,278 0,5 interacting protein 3 8043283 KDM3A lysine (K)-specific demethylase 3A 1,274 0,453 7923991 PLXNA2 plexin A2 1,252 0,481 8163618 TNFSF15 tumor necrosis
    [Show full text]
  • Supplementary Data
    SUPPLEMENTAL INFORMATION A study restricted to chemokine receptors as well as a genome-wide transcript analysis uncovered CXCR4 as preferentially expressed in Ewing's sarcoma (Ewing's sarcoma) cells of metastatic origin (Figure 4). Transcriptome analyses showed that in addition to CXCR4, genes known to support cell motility and invasion topped the list of genes preferentially expressed in metastasis-derived cells (Figure 4D). These included kynurenine 3-monooxygenase (KMO), galectin-1 (LGALS1), gastrin-releasing peptide (GRP), procollagen C-endopeptidase enhancer (PCOLCE), and ephrin receptor B (EPHB3). KMO, a key enzyme of tryptophan catabolism, has not been linked to metastasis. Tryptophan and its catabolites, however, are involved in immune evasion by tumors, a process that can assist in tumor progression and metastasis (1). LGALS1, GRP, PCOLCE and EPHB3 have been linked to tumor progression and metastasis of several cancers (2-4). Top genes preferentially expressed in L-EDCL included genes that suppress cell motility and/or potentiate cell adhesion such as plakophilin 1 (PKP1), neuropeptide Y (NPY), or the metastasis suppressor TXNIP (5-7) (Figure 4D). Overall, L-EDCL were enriched in gene sets geared at optimizing nutrient transport and usage (Figure 4D; Supplementary Table 3), a state that may support the early stages of tumor growth. Once tumor growth outpaces nutrient and oxygen supplies, gene expression programs are usually switched to hypoxic response and neoangiogenesis, which ultimately lead to tumor egress and metastasis. Accordingly, gene sets involved in extracellular matrix remodeling, MAPK signaling, and response to hypoxia were up-regulated in M-EDCL (Figure 4D; Supplementary Table 4), consistent with their association to metastasis in other cancers (8, 9).
    [Show full text]
  • Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Fall 2010 Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Renuka Nayak University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Computational Biology Commons, and the Genomics Commons Recommended Citation Nayak, Renuka, "Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress" (2010). Publicly Accessible Penn Dissertations. 1559. https://repository.upenn.edu/edissertations/1559 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1559 For more information, please contact [email protected]. Coexpression Networks Based on Natural Variation in Human Gene Expression at Baseline and Under Stress Abstract Genes interact in networks to orchestrate cellular processes. Here, we used coexpression networks based on natural variation in gene expression to study the functions and interactions of human genes. We asked how these networks change in response to stress. First, we studied human coexpression networks at baseline. We constructed networks by identifying correlations in expression levels of 8.9 million gene pairs in immortalized B cells from 295 individuals comprising three independent samples. The resulting networks allowed us to infer interactions between biological processes. We used the network to predict the functions of poorly-characterized human genes, and provided some experimental support. Examining genes implicated in disease, we found that IFIH1, a diabetes susceptibility gene, interacts with YES1, which affects glucose transport. Genes predisposing to the same diseases are clustered non-randomly in the network, suggesting that the network may be used to identify candidate genes that influence disease susceptibility.
    [Show full text]